OncoBriefs - Oncology Research News

Like the Zodiac cipher before it cracked, RNF43 has spent years giving cancer geneticists just enough clues to be annoying.

In the hushed savanna of the human brain, the glioblastoma stalks its territory, not with claws or dramatic music, but with suspiciously well-managed energy bills.

A tumor-draining lymph node and airport security have more in common than any of us wanted: both are supposed to catch dangerous things before they spread, and both can become weirdly inefficient when the wrong crowd starts influencing the process.

One minute you're reheating coffee for the third time, and the next you're reading about a rare head and neck cancer getting treated with drug-filled microscopic fat bubbles. Life comes at you fast. And honestly, cancer biology comes at you faster - usually wearing a fake mustache and trying to...

What makes a cancer cell itself: its genes, its hiding place, or the enemies it manages to outlive?

Cellular engineering can look a lot like a home remodel gone feral - walls knocked out, wiring exposed, nobody filed permits, and somehow the whole structure is still standing. This paper asks a sneaky question: while a tumor is busy turning the house into an illegal open-concept disaster, is your...

A circular RNA sets off like a traveler who has burned the map, tied the road into a loop, and somehow made itself harder for the cellular border patrol to deport. That, in a molecule-sized nutshell, is why scientists keep staring at these little RNA rings with the expression usually reserved for...

2012: scientists name ferroptosis, a strange iron-fueled way for cells to die. 2017: CAR-T therapy becomes the oncology equivalent of handing T cells a badge, a GPS, and permission to kick doors in. 2026: Kong and colleagues report the awkward plot twist: after CAR-T cells surge into battle, excess...

Math problem: if measles can infect about 9 out of 10 non-immune people who get close to it, how many viral headaches do you get from one under-vaccinated room? Answer: enough to make public health spreadsheets start smoking.

The harvest from this study is surprisingly practical: the researchers found a possible new weak spot, PLOD2, then built an early proof-of-concept compound that degraded it and slowed pancreatic cancer growth in living models. Now let’s rewind through the garden path, because cancer biology never...

In the video game version of pancreatic cancer, the tumor is the final boss, chemotherapy is your slightly underpowered sword, and the tumor microenvironment is that unfair level where the floor is lava, the doors lock behind you, and someone keeps stealing your health packs.

Parenting a body is mostly telling rogue cells, "No, you may not climb the chromatin, rewrite the household rules, and start a leukemia franchise before dinner."

In the next 60 seconds inside your body, your colon will keep doing its extremely unglamorous job: squeezing yesterday's nachos along, shedding old cells, hosting a microbiome party with questionable guest control, and quietly hoping nobody starts a tiny cellular reboot of Breaking Bad. Most of the...

Dear immune system, we need to talk. While you were running your usual security ops, some colorectal cancer cells apparently rebranded themselves as fetal gut tissue, hired the neighborhood fibroblasts as growth consultants, and started laying groundwork for metastasis before the big launch. Not...

What is a cell, really, if not a tiny employee trying to figure out whether today’s purpose is "file paperwork," "fight cancer," or "quietly panic in a lymph node"?

I have a confession: for a long time, scientists looked at the dense scar-like thicket around pancreatic tumors and thought, more or less, “Aha, the villain’s hedge - rip it out.” Reasonable! If a tumor is an invasive weed, and the garden is choked with brambles, you reach for the shears. But...

A fly on the wall in this lab would see scientists coaxing breast cancer samples into revealing their inner scaffolding, while computers squint at 3D images like tiny art critics muttering, “Ah yes, the malignant lattice period.”

Pancreatic ductal adenocarcinoma, or PDAC, has spent decades acting like the worst kind of biotech founder: overconfident, under-regulated, and somehow still raising capital from your body’s blood supply.

We gather today to remember the old treatment plan for advanced head-and-neck adenoid cystic carcinoma: watch carefully, try something reasonable, cross several fingers, and hope the tumor forgets it has places to be.

Somewhere in the evolutionary group chat, Cephalotaxus trees apparently decided that photosynthesis was not enough. They also started making elaborate alkaloids, including homoharringtonine, better known in drug form as omacetaxine, a compound used against certain leukemias. Casual hobby. Very "I...